Titan Pharmaceuticals Ownership | Who Owns Titan Pharmaceuticals?

Titan Pharmaceuticals Ownership Summary

Titan Pharmaceuticals is owned by 0.01% institutional investors, 8.95% insiders, and 91.05% retail investors. Tower research capital llc (trc) is the largest institutional shareholder, holding 0.04% of TTNP shares. Fidelity Extended Market Index is the top mutual fund, with 0.33% of its assets in Titan Pharmaceuticals shares.

TTNP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Titan Pharmaceuticals	0.01%	8.95%	91.05%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tower research capital llc (trc)	469.00	0.04%	$2.25K
Corecap advisors	88.00	0.01%	$147.00
Advisor group	10.00	0.00%	$35.00
Caldwell sutter capital	1.00	0.00%	$2.00
Global wealth strategies & associates	2.00	0.00%	$3.00
St germain d j	1.00	0.00%	$2.00
Wells fargo & company/mn	-	-	-
Morgan stanley	-	-	-
Blackrock funding, inc. /de	-	-	-
Raymond james financial	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tower research capital llc (trc)	469.00	0.00%	$2.25K
St germain d j	1.00	-	$2.00
Drw securities	-	-	-
Renaissance	-	-	-
Advisor group	10.00	-	$35.00
Caldwell sutter capital	1.00	-	$2.00
Nemes rush group	-	-	-
Group one trading	-	-	-
Ubs group	-	-	-
Wells fargo & company/mn	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Tower research capital llc (trc)	469.00	0.00%	469.00
Caldwell sutter capital	1.00	-	-
St germain d j	1.00	-	-
Advisor group	10.00	-	-
Global wealth strategies & associates	2.00	-	-

Top Sellers

Holder	Shares	% Assets	Change
Drw securities	-	-	-21.27K
Renaissance	-	-	-11.38K
Marex group	-	-	-10.66K
Ubs group	-	-	-480.00
Group one trading	-	-	-12.00

New Positions

Holder	Shares	% Assets	Change	Value
Tower research capital llc (trc)	469.00	0.00%	469.00	$2.25K

Sold Out

Holder	Change
Raymond james financial	-1.00
Wells fargo & company/mn	-1.00
Nemes rush group	-1.00
Westside investment management	-1.00
Ransom advisory	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	4	-76.47%	92	-99.59%	-	0.15%	-	-100.00%	-	-100.00%
Sep 30, 2025	17	-15.00%	22,362	-40.66%	2	12.35%	3	-40.00%	1	-50.00%
Jun 30, 2025	20	17.65%	37,691	156.26%	4	159.25%	5	-28.57%	1	-
Mar 31, 2025	17	21.43%	14,708	410.69%	1	1567.76%	7	600.00%	1	-66.67%
Dec 31, 2024	14	-6.67%	2,880	-82.86%	-	9.48%	1	-75.00%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	4.38K	0.33%	-31.00
Vanguard Institutional Extnd Mkt Idx Tr	2.82K	0.21%	-1.28K
Fidelity Nasdaq Composite Index	1.51K	0.11%	-
Fidelity Series Total Market Index	985.00	0.07%	-
Northern Trust Extended Eq Market Idx	293.00	0.02%	-
NT Ext Equity Mkt Idx Fd - L	293.00	0.02%	-
SSgA U.S. Extended Market Index Class I	3.10K	0.02%	-
NT Ext Equity Mkt Idx Fd - NL	161.00	0.01%	-
State St US Extended Mkt Indx NL Cl C	155.00	0.01%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	125.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 21, 2023	Lazar David E.	Chief Executive Officer	Sell	$441.65K
Jun 21, 2023	Lazar David E.	Chief Executive Officer	Sell	$441.65K
Jan 25, 2023	Lazar David E.	Chief Executive Officer	Buy	$20.07K
Jan 24, 2023	Lazar David E.	Chief Executive Officer	Buy	$36.22K
Jul 06, 2022	Activist Investing LLC		Buy	$739.01K

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	-	-
2023 Q3	-	-
2023 Q2	-	2
2023 Q1	2	-
2022 Q3	1	-

TTNP Ownership FAQ

Who Owns Titan Pharmaceuticals?

Titan Pharmaceuticals shareholders are primarily institutional investors at 0.01%, followed by 8.95% insiders and 91.04% retail investors. The average institutional ownership in Titan Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Titan Pharmaceuticals falls below.

Who owns the most shares of Titan Pharmaceuticals?

Titan Pharmaceuticals’s largest shareholders are Tower research capital llc (trc) (469 shares, 0.04%), Corecap advisors (88 shares, 0.01%), and Advisor group (10 shares, 0.00%). Together, they hold 0.05% of Titan Pharmaceuticals’s total shares outstanding.

Does Blackrock own Titan Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Titan Pharmaceuticals.

Who is Titan Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Titan Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 469 Titan Pharmaceuticals shares, valued at 2.25K$.

Who is the top mutual fund holder of Titan Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Titan Pharmaceuticals shares, with 0.33% of its total shares outstanding invested in 4.38K Titan Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools